Background: Elevated microvesicle (MV) levels are potential biomarkers of coronavirus disease 2019 (COVID-19). We compared different types of microvesicles (total microvesicles, TMVs), platelet-derived microvesicles (PMVs), endothelium-derived microvesicles (EMVs), and tissue factor-bearing microvesicles (TF-MVs). Objectives: We investigated the correlations between microvesicles and D-dimers, as well as between microvesicles and COVID-19 severity. Materials and methods: A systematic literature search was conducted in PubMed, Web of Science, Scopus, and ScienceDirect to identify relevant studies comparing microvesicle types between patients with COVID-19 and healthy controls. Pooled estimates of the standardized mean difference (SMD) for each MV type were calculated using RevMan 5.4, along with the corresponding 95% confidence intervals (CIs). Results: This meta-analysis included six studies comprising 183 COVID-19 patients and 135 healthy controls for quantitative analysis. Compared with controls, COVID-19 patients presented significantly higher levels of circulating TMVs, PMVs, EMVs, and TF-MVs (TMVs: SMD=4.27, 95% CI 2.18-6.36, p<0.0001; PMVs: SMD=2.07, 95% CI 0.99-3.15, p=0.0002; EMVs: SMD=1.20, 95% CI 0.56-1.84, p=0.0002; and TF-MVs: SMD=2.56, 95% CI 1.98-3.15, p<0.00001). D-dimer levels were correlated with MV levels (N=82, r=0.430, 95% CI 0.227-0.592, p<0.0001). In general, MVs were correlated with COVID-19 severity (N=168; r=0.942; 95% CI, 0.558-0.993; p=0.002). Conclusion: Patients with severe COVID-19 had elevated levels of TMVs, PMVs, EMVs, and TF-MVs. Therefore, MVs may contribute to the procoagulant effects associated with prognostic and severity biomarkers of COVID-19.